Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity

Antifungal Prophylaxis in Lung Transplantation-A World-wide Survey

(2011) C. F. Neoh et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients

(2011) Kelong Han et al.   CLINICAL PHARMACOKINETICS

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

(2011) Shahid Husain et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Bioavailability and Population Pharmacokinetics of Voriconazole in Lung Transplant Recipients

(2010) K. Han et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bronchial blood supply after lung transplantation without bronchial artery revascularization

(2010) Mark R Nicolls et al.   Current Opinion in Organ Transplantation

Age-specific complications among lung transplant recipients 60 years and older

(2010) Aniket Vadnerkar et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Impact of Therapeutic Drug Monitoring of Voriconazole in a Pediatric Population

(2010) Roger J. M. Brüggemann et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Serial Plasma Voriconazole Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) S. M. Trifilio et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Voriconazole Pharmacokinetics in Liver Transplant Recipients

(2009) H. J. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hepatic Safety of Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation

(2009) I. Amigues et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Voriconazole concentrations and outcome of invasive fungal infections

(2009) S. Miyakis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Therapeutic Drug Monitoring of Antifungals: Pharmacokinetic and Pharmacodynamic Considerations

(2009) Jeannina Smith et al.   THERAPEUTIC DRUG MONITORING

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients

(2009) M. Berge et al.   Transplant Infectious Disease

Clinical Application of Voriconazole Concentrations in the Treatment of Invasive Aspergillosis

(2008) Ashley Howard et al.   ANNALS OF PHARMACOTHERAPY

Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications

(2008) D. Andes et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES

Therapeutic Drug Monitoring of Voriconazole in a Child With Invasive Aspergillosis Requiring Extracorporeal Membrane Oxygenation

(2008) Roger J M Brüggemann et al.   THERAPEUTIC DRUG MONITORING

Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes

(2007) A. Pascual et al.   CLINICAL INFECTIOUS DISEASES